FA9D4D02-3B2D-4921-AC7F-67E8C2BB8CB1MRC Clinical Trials Unit as the London Hub for Trials Methodology ResearchResearch GrantMC_EX_G0800814C008C651-F5B0-4859-A334-5F574AB6B57CMRCSUPPLEMENTARY_UNIT_AWARDS1947802F0C47B5E-A30F-4BB1-8F21-941E53EC6E4DInhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2-3 randomised trial.The lancet. Gastroenterology & hepatologyf8fc7aab55825204e4ea4a91d8c76fa9Adams R2018-01-01http://dx.doi.org/10.1016/s2468-1253(17)30394-129254887http://ukpmc.ac.uk/abstract/MED/29254887http://europepmc.org/abstract/MED/2925488733Journal Article/Review5a999e37241945.08840660